140 related articles for article (PubMed ID: 36116753)
1. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.
Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
3. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening.
Kooyker A; de Jonge L; Toes-Zoutendijk E; Spaander M; van Vuuren H; Kuipers E; van Kemenade F; Ramakers C; Dekker E; Nagtegaal I; van Leerdam M; Lansdorp-Vogelaar I
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3424-3432.e2. PubMed ID: 37619823
[TBL] [Abstract][Full Text] [Related]
6. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
8. The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study.
Tran TN; Hoeck S; De Schutter H; Janssens S; Peeters M; Van Hal G
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674409
[TBL] [Abstract][Full Text] [Related]
9. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.
Chiu HM; Jen GH; Wang YW; Fann JC; Hsu CY; Jeng YC; Yen AM; Chiu SY; Chen SL; Hsu WF; Lee YC; Wu MS; Wu CY; Jou YY; Chen TH
Gut; 2021 Dec; 70(12):2321-2329. PubMed ID: 33495268
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract][Full Text] [Related]
12. [National population screening for colorectal carcinoma in the Netherlands: results of the first years since the implementation in 2014].
Elferink MAG; Toes-Zoutendijk E; Vink GR; Lansdorp-Vogelaar I; Meijer GA; Dekker E; Lemmens VEPP
Ned Tijdschr Geneeskd; 2018; 162():D2283. PubMed ID: 29519262
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
14. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
[TBL] [Abstract][Full Text] [Related]
15. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
Lee YC; Fann JC; Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Hsu CY; Hsu WF; Wu MS; Chen HH
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1332-1340.e3. PubMed ID: 30391435
[TBL] [Abstract][Full Text] [Related]
16. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
17. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade.
Kooyker AI; Verbeek WH; van den Berg JG; Tesselaar ME; van Leerdam ME
United European Gastroenterol J; 2020 Feb; 8(1):59-67. PubMed ID: 32213058
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Advanced Colorectal Cancer Detected by Fecal Immunochemical Test Screening in Participants with a Negative Result the Previous Year.
Hasegawa R; Yashima K; Ikebuchi Y; Sasaki S; Yoshida A; Kawaguchi K; Isomoto H
Yonago Acta Med; 2020 Feb; 63(1):63-69. PubMed ID: 32158335
[TBL] [Abstract][Full Text] [Related]
19. Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study.
Bos ACRK; Matthijsen RA; van Erning FN; van Oijen MGH; Rutten HJT; Lemmens VEPP
Ann Surg Oncol; 2018 Feb; 25(2):414-421. PubMed ID: 29159744
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location.
Niedermaier T; Tikk K; Gies A; Bieck S; Brenner H
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2920-2928.e6. PubMed ID: 31988043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]